Surgical Revascularization Outcomes After Oral Anticoagulation or Antiplatelets

Surgical Coronary Revascularization Outcomes After Oral Anticoagulation or Antiplatelet Strategies

The primary purpose of this study is to evaluate whether treatment with oral anticoagulation or oral anticoagulation and aspirin is better than aspirin alone in cardiovascular outcomes and saphenous graft patency in patients submitted to coronary artery bypass graft.

Inclusion Criteria:

• Patients referred to coronary artery bypass graft and at least one saphenous vein graft

Exclusion Criteria:

• Need for dual antiplatelet therapy, other non-aspirin antiplatelet therapy or oral anticoagulant therapy
• Stroke within 1 month or any history of hemorrhagic or lacunar stroke
• Estimated glomerular filtration rate (eGFR)<15 mL/min